When healthcare data contains biases or suffers from missingness, the resulting analyses, predictions, and interventions may inadvertently perpetuate or even amplify existing inequalities. In the third instalment of our data assets series, we explore the nature of these data challenges and offer practical strategies for mitigation. Understanding Bias in Healthcare Data Bias in healthcare data… Continue reading Addressing Biases and Missingness in Healthcare Data
Category: News and insights
Dr Afyouni Discusses Effective Data Housekeeping in Drug Discovery
We are pleased to share that Soroosh Afyouni, PhD, Head of Health Data Sciences at bioXcelerate AI, has been featured in an insightful article discussing the critical role of effective data management in accelerating drug discovery and development. The article, titled Accelerating Drug Discovery and Development with Effective Data Housekeeping, explores how the vast and… Continue reading Dr Afyouni Discusses Effective Data Housekeeping in Drug Discovery
Managing Data Complexity in Healthcare
In the first instalment of our data assets series, we discussed the crucial role large population health data resources, such as UK Biobank, play in drug discovery and development by providing the statistical influence needed to uncover subtle yet impactful insights that advance pharmaceutical innovation. Now, we turn our attention to the challenges of managing… Continue reading Managing Data Complexity in Healthcare
bioXcelerate AI at ASHG 2024: Presenting Genetic Research with ImpMap and SwitchStep
We’re thrilled to announce that our Managing Director and Chief Scientist, Chris Foley, PhD, is representing bioXcelerate AI at this year’s American Society of Human Genetics (ASHG) Annual Meeting. Held in Denver, Colorado, the ASHG 2024 conference brings together thought leaders, researchers, and innovators from around the globe to explore the latest advancements in human… Continue reading bioXcelerate AI at ASHG 2024: Presenting Genetic Research with ImpMap and SwitchStep
Building Data Assets in Drug Discovery
Large population-based cohort studies like UK Biobank are crucial for drug discovery, providing the statistical power needed to identify small effects that would otherwise go unnoticed. Data assets can be generated in-house or accessed from external sources, each approach having its own advantages and challenges. Pharmaceutical research demands structured, quality data, with drug development being… Continue reading Building Data Assets in Drug Discovery
Methods in Applied Genetic Epidemiology 2022
View the Full Frontiers Editorial Genetic epidemiology holds immense potential to revolutionise our understanding of human disease aetiology, progression, and prevention. In a recently published editorial in Frontiers, our Managing Director and Chief Scientist, Chris Foley PhD, and Director of Health Data Science, Zhana Kuncheva PhD, discuss the critical developments and challenges in the field.… Continue reading Methods in Applied Genetic Epidemiology 2022
Unleashing the power of genomics with population scale proteomics
At the recent Nordic Conference on Future Health, Chris Foley PhD, our Managing Director and Chief Scientist, was a distinguished guest speaker at Olink’s workshop titled Navigating the UKB Plasma Proteomics Data to Explore Protein Variability, Disease Risk Scores, and Proteogenomic Associations. This workshop focused on the UK Biobank Pharma Proteomics Project (UKB-PPP), which stands… Continue reading Unleashing the power of genomics with population scale proteomics
Dr Afyouni Discusses AI in Healthcare at the RSSI
We are delighted to share that Dr Soroosh Afyouni, PhD, Head of Health Data Science at bioXcelerate AI, was a panellist at the Royal Statistical Society (RSS) International Conference 2024, to discuss AI in healthcare. The RSS Conference is the UK’s premier event for statistics and data science, bringing together over 600 professionals from more… Continue reading Dr Afyouni Discusses AI in Healthcare at the RSSI
Dr Zhana Kuncheva on the AI Revolution in Healthcare
We are excited to announce that Zhana Kuncheva, our Director of Health Data Science, recently published an insightful article in Pharma IQ titled “Unlocking Health Data’s Potential: The AI Revolution in Healthcare.” This article explores how artificial intelligence (AI) is transforming healthcare by unlocking the value hidden in vast data reserves, with a particular focus… Continue reading Dr Zhana Kuncheva on the AI Revolution in Healthcare
Breakthrough Research Spotlighted in Pharma IQ
Our Managing Director & Chief Scientist, Dr Chris Foley, and Dr Riccardo Marioni, Chair of Molecular Epidemiology of Ageing at the University of Edinburgh, were recently interviewed by Pharma IQ about their groundbreaking research. This study, a collaboration between bioXcelerate AI, Biogen, and the University of Edinburgh, marks a significant advancement in predictive health. In… Continue reading Breakthrough Research Spotlighted in Pharma IQ